Loading...
Observational studies of risk for cataracts with statin use have yielded conflicting results. Using data collected between 2003 and 2010 in the clinical and administrative database of a military healthcare system in Texas, researchers conducted a retrospective cohort analysis that involved 6972 pairs of statin users and nonusers. Statin users were defined as patients who received at least 90-day supplies of statin medications at baseline (mean duration of statin use, ≈5 years). Participant pairs were matched for 44 clinical, medication, and healthcare variables associated with either likelihood of receiving a statin or risk for developing cataracts.
During up to 6 years of follow-up, risk for developing cataracts was 35.5% among statin users and 33.5% among nonusers — a significant difference. An increased risk associated with statin use also was noted in a secondary analysis restricted to patients with few comorbidities.
Leuschen J et al. Association of statin use with cataracts: A propensity score–matched analysis. JAMA Ophthalmol 2013 Sep 19; [e-pub ahead of print]. (http://dx.doi.org/10.1001/jamaophthalmol.2013.4575)
Comment
The clinical trial needed to confirm these results is unlikely to be done. The study design and analyses here are sufficiently robust to support caution in prescribing statins to patients who might benefit only marginally, particularly patients at low risk for cardiovascular disease.